##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H227-301222-ROCHE_S175_R
1	2491183	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=3780;GeneNames=PLCH2;GeneIDs=9651;Aliases=PLC-L4,PLC-eta2,PLCL4,PLCeta2;Genes=1;TranscriptNameClinicallyRelevant=NM_014638.4;OverlappingExonsClinicallyRelevant=11-12;HGVSg=NC_000001.11:g.2491183_2494962dup;HGVScClinicallyRelevant=NM_014638.4:c.1516-9_1752+14dup;HGVSpClinicallyRelevant=NP_055453.2:p.A506_K584dup;ISCNCytobandNotation=dup(1)p36.32;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=2494962	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:141.68:3.36484:1.47555:3.31922429503833e-05:PLCH2::PLCH2:NM_014638.4:VUS:2L0ThiscnvpartiallyoverlapsthePLCH2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	3595332	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=MEGF6;GeneIDs=1953;Aliases=EGFL3;Genes=1;TranscriptNameClinicallyRelevant=NM_001409.4;OverlappingExonsClinicallyRelevant=3;HGVSg=NC_000001.11:g.3595332_3595451dup;HGVScClinicallyRelevant=NM_001409.4:c.267-4_376+6dup;HGVSpClinicallyRelevant=NP_001400.3:p.A126Efs*89;ISCNCytobandNotation=dup(1)p36.32;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=3595451	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:148.158:4.46779:1.62901:9.76366677082126e-05:MEGF6::MEGF6:NM_001409.4:VUS:2L0ThiscnvpartiallyoverlapstheMEGF6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	17634487	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=4;Span=120;GeneNames=ARHGEF10L;GeneIDs=55160;Aliases=GrinchGEF;Genes=1;TranscriptNameClinicallyRelevant=NM_018125.4;OverlappingExonsClinicallyRelevant=17;HGVSg=NC_000001.11:g.17634487_17634606dup;HGVScClinicallyRelevant=NM_018125.4:c.1731-61_1745+44dup;HGVSpClinicallyRelevant=NP_060595.3:p.P578_R582dup;ISCNCytobandNotation=dup(1)p36.13;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=17634606	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:87.8833:4.97706:1.70891:1.38380004278984e-05:ARHGEF10L::ARHGEF10L:NM_018125.4:VUS:2L0ThiscnvpartiallyoverlapstheARHGEF10Lgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	31668768	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=2;Span=2930;GeneNames=COL16A1;GeneIDs=1307;Aliases=447AA,FP1572;Genes=1;TranscriptNameClinicallyRelevant=NM_001856.4;OverlappingExonsClinicallyRelevant=48-50;HGVSg=NC_000001.11:g.31668768_31671697dup;HGVScClinicallyRelevant=NM_001856.4:c.3106-38_3249+34dup;HGVSpClinicallyRelevant=NP_001847.3:p.M1040_G1087dup;ISCNCytobandNotation=dup(1)p35.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=31671697	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:79.8195:2.37492:1.37606:0.000346998477602514:COL16A1:COL16A1:COL16A1:NM_001856.4:VUS:3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	103571593	.	N	<DUP>	.	.	Type=Gain;Targets=16;Samples2=3;Span=52625;GeneNames=AMY2A,AMY2B;GeneIDs=280,279;Aliases=AMY2,AMY3,HXA;Genes=2;TranscriptNameClinicallyRelevant=NM_000699.4,NM_001387437.1;OverlappingExonsClinicallyRelevant=1-9,All;HGVSg=NC_000001.11:g.103571593_103624217dup;HGVScClinicallyRelevant=NM_000699.4:c.1_1342dup,.;HGVSpClinicallyRelevant=NP_000690.1:p.W449Efs*32,.;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=frameshift_variant,.;RegionClinicallyRelevant=exon,.;Region=1:103477937-103635416,1:103556018-103635416,1:103560121-103601707,1:103563013-103697364,1:103568703-103583708,1:103570917-103778627,1:103579055-103594323,1:103582270-103615727,1:103595065-103612647,1:103601627-103633444,1:103611243-103625771;Span2=157480,79399,41587,134352,15006,207711,15269,33458,17583,31818,14529;OverlapType=Within Region,Within Region,Partial Overlap,Within Region,Partial Overlap,Within Region,Contains Region,Contains Region,Contains Region,Partial Overlap,Partial Overlap;Name=gssvG1324,gssvG1335,gssvG1342,gssvG1328,gssvG1363,gssvG1322,gssvG1358,gssvG1345,gssvG1356,gssvG1347,gssvG1361;Frequency=0.0022,0.0432,0.0153,0.0043,0.233,0.021,0.0019,0.0117,0.002,0.0099,0.0113;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=1:103561257-103616324,1:103566617-103589737,1:103566617-103635416,1:103566617-103725600,1:103578005-103593164,1:103579607-103594323;Span3=55068,23121,68800,158984,15160,14717;OverlapType2=Partial Overlap,Partial Overlap,Within Region,Within Region,Contains Region,Contains Region;Type3=Duplication,Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.125,0.0153742,0.0642,0.0214563,0.0177515,0.025;DeletionFrequency=0,0,0,0,0,0;DuplicationFrequency=0.125,0.0153742,0.0642,0.0214563,0.0177515,0.025;END=103624217	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:268.973:2.7805:1.54831:2.14800126828849e-22:AMY2A,AMY2B::AMY2A:NM_000699.4:Benign:2L0ThiscnvpartiallyoverlapstheAMY2Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	109280079	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=1990;GeneNames=PSRC1;GeneIDs=84722;Aliases=DDA3,FP3214;Genes=1;TranscriptNameClinicallyRelevant=NM_001032291.3;OverlappingExonsClinicallyRelevant=4-8;HGVSg=NC_000001.11:g.109280079_109282068dup;HGVScClinicallyRelevant=NM_001032291.3:c.78-8_1002dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p13.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=109282068	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:131.295:2.51437:1.28795:1.1618508447687e-05:PSRC1::PSRC1:NM_001032291.3:VUS:2L0ThiscnvpartiallyoverlapsthePSRC1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	149073754	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=2;Span=5517;GeneNames=NBPF9;GeneIDs=400818;Aliases=AE01;Genes=1;TranscriptNameClinicallyRelevant=NM_001388367.1;OverlappingExonsClinicallyRelevant=9-13;HGVSg=NC_000001.11:g.149073754_149079270dup;HGVScClinicallyRelevant=NM_001388367.1:c.279-49_1091+14dup;HGVSpClinicallyRelevant=NP_001375296.1:p.S101_H371dup;ISCNCytobandNotation=dup(1)q21.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;Region=1:149065822-149085330;Span2=19509;OverlapType=Within Region;Name=gssvG1915;Frequency=0.22;Type2=Gain;Region2=1:149070691-149085328,1:149075799-149078925,1:149076863-149078044;Span3=14638,3127,1182;OverlapType2=Within Region,Contains Region,Contains Region;Type3=Duplication,Duplication,Duplication;Frequency2=0.025,0.00591716,0.025;DeletionFrequency=0,0,0;DuplicationFrequency=0.025,0.00591716,0.025;END=149079270	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:264.48:2.91608:1.60614:1.20822768013959e-08:NBPF9::NBPF9:NM_001388367.1:VUS:2L0ThiscnvpartiallyoverlapstheNBPF9genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	161513853	.	N	<DUP>	.	.	Type=Gain;Targets=12;Samples2=1;Span=81779;GeneNames=FCGR2A,FCGR2C,FCGR3A,HSPA6,TRG-GCC2-1,TRG-TCC2-6,TRL-CAG1-6,TRN-GTT1-1;GeneIDs=2212,100189380,3310,100189018,100189011,100189126,2214,9103;Aliases=CD32,CD32A,CDw32,FCG2,FCGR2,FCGR2A1,FcGR,FcgammaRIIa,IGFR2;Genes=8;TranscriptNameClinicallyRelevant=NM_001136219.3,NR_047648.1,NM_000569.8,NM_002155.5,TRG-GCC2-1,TRG-TCC2-6,TRL-CAG1-6,TRN-GTT1-1;OverlappingExonsClinicallyRelevant=6-7,1-6,All,All,All,All,All,All;HGVSg=NC_000001.11:g.161513853_161595631dup;HGVScClinicallyRelevant=NM_001136219.3:c.743-42_954dup,.,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.;ISCNCytobandNotation=dup(1)q23.3;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.,.,.,.,.,.;RegionClinicallyRelevant=exon,.,.,.,.,.,.,.;Region=1:161506699-161700539,1:161513788-161555015;Span2=193841,41228;OverlapType=Within Region,Partial Overlap;Name=gssvG2599,gssvG2607;Frequency=0.0505,0.0257;Type2=Gain,Gain;Region2=1:161439274-161676968,1:161442200-161574860,1:161510156-161676968;Span3=237695,132661,166813;OverlapType2=Within Region,Partial Overlap,Within Region;Type3=Duplication,Duplication,Duplication;Frequency2=0.924444,0.025,0.971111;DeletionFrequency=0,0,0;DuplicationFrequency=0.924444,0.025,0.971111;END=161595631	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:200.982:1.92024:1.33167:6.42935206370573e-09:FCGR2A,FCGR2C,FCGR3A,HSPA6,TRG-GCC2-1,TRG-TCC2-6,TRL-CAG1-6,TRN-GTT1-1::FCGR2A:NM_001136219.3:Benign:2L0ThiscnvpartiallyoverlapstheFCGR2Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	207563854	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=4;Span=4277;GeneNames=CR1;GeneIDs=1378;Aliases=C3BR,C4BR,CD35,KN;Genes=1;TranscriptNameClinicallyRelevant=NM_000651.6;OverlappingExonsClinicallyRelevant=22-25;HGVSg=NC_000001.11:g.207563854_207568130dup;HGVScClinicallyRelevant=NM_000651.6:c.3587-10_4171+88dup;HGVSpClinicallyRelevant=NP_000642.3:p.V1196_L1390dup;ISCNCytobandNotation=dup(1)q32.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;Region2=1:207558604-207567633;Span3=9030;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=207568130	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:218.553:1.89971:1.42403:0.000221931795764992:CR1::CR1:NM_000651.6:Benign:2L0ThiscnvpartiallyoverlapstheCR1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
2	96025912	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=4;Span=6237;GeneNames=GPAT2;GeneIDs=150763;Aliases=CT123;Genes=1;TranscriptNameClinicallyRelevant=NM_001321527.2;OverlappingExonsClinicallyRelevant=3-12;HGVSg=NC_000002.12:g.96025912_96032148dup;HGVScClinicallyRelevant=NM_001321527.2:c.64-2_1238+18dup;HGVSpClinicallyRelevant=NP_001308456.1:p.C413Wfs*11;ISCNCytobandNotation=dup(2)q11.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=96032148	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:91.55:2.44888:1.43235:0.00022351543650415:GPAT2::GPAT2:NM_001321527.2:VUS:2L0ThiscnvpartiallyoverlapstheGPAT2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	99147420	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=1;Span=38869;GeneNames=C2orf15,LIPT1,MITD1,MRPL30,TSGA10;GeneIDs=80705,150590,51601,129531,51263;Aliases=CEP4L,CT79,SPGF26;Genes=5;TranscriptNameClinicallyRelevant=NM_144706.4,NM_145199.3,NM_138798.3,NM_145212.4,NM_025244.4;OverlappingExonsClinicallyRelevant=3-4,All,All,1-2,1;HGVSg=NC_000002.12:g.99147420_99186288dup;HGVScClinicallyRelevant=.,.,.,NM_145212.4:c.1_51+34dup,.;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(2)q11.2;SequenceOntologyClinicallyRelevant=.,.,.,transcript_ablation,.;RegionClinicallyRelevant=.,.,.,exon,.;END=99186288	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:125.638:2.39495:1.27377:3.61573892132867e-11:C2orf15,LIPT1,MITD1,MRPL30,TSGA10::MRPL30:NM_145212.4:VUS:2L0ThiscnvpartiallyoverlapstheMRPL30genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps5proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	131120936	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=1;Span=9865;GeneNames=PLEKHB2;GeneIDs=55041;Aliases=EVT2;Genes=1;TranscriptNameClinicallyRelevant=NM_001100623.2;OverlappingExonsClinicallyRelevant=2-5;HGVSg=NC_000002.12:g.131120936_131130800del;HGVScClinicallyRelevant=NM_001100623.2:c.1_333+40del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(2)q21.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=131130800	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:47.413:-2.67288:0.606794:2.67869431554038e-06:PLEKHB2::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
3	50182902	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=378;GeneNames=SEMA3F;GeneIDs=6405;Aliases=SEMA-IV,SEMA4,SEMAK;Genes=1;TranscriptNameClinicallyRelevant=NM_004186.5;OverlappingExonsClinicallyRelevant=10-11;HGVSg=NC_000003.12:g.50182902_50183279dup;HGVScClinicallyRelevant=NM_004186.5:c.904-2_1088+24dup;HGVSpClinicallyRelevant=NP_004177.3:p.S364Tfs*17;ISCNCytobandNotation=dup(3)p21.31;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=50183279	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:133.487:3.54107:1.46024:1.23950786047006e-05:SEMA3F::SEMA3F:NM_004186.5:VUS:2L0ThiscnvpartiallyoverlapstheSEMA3Fgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	94094130	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=32369;GeneNames=NSUN3;GeneIDs=63899;Aliases=COXPD48,MST077,MSTP077;Genes=1;TranscriptNameClinicallyRelevant=NM_022072.5;OverlappingExonsClinicallyRelevant=4-6;HGVSg=NC_000003.12:g.94094130_94126498dup;HGVScClinicallyRelevant=NM_022072.5:c.467-10_1023dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(3)q11.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=94126498	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:179.67:3.71042:1.38506:1.91465652971446e-08:NSUN3::NSUN3:NM_022072.5:VUS:2L0ThiscnvpartiallyoverlapstheNSUN3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	134758887	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=DDX46;GeneIDs=9879;Aliases=PRPF5,Prp5;Genes=1;TranscriptNameClinicallyRelevant=NM_001300860.2;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000005.10:g.134758887_134759006dup;HGVScClinicallyRelevant=NM_001300860.2:c.1_17+51dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(5)q31.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=134759006	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:137.55:4.69006:1.70978:4.26053154527627e-05:DDX46::DDX46:NM_001300860.2:VUS:2L0ThiscnvpartiallyoverlapstheDDX46genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
6	36748184	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=CPNE5;GeneIDs=57699;Aliases=COPN5,CPN5;Genes=1;TranscriptNameClinicallyRelevant=NM_020939.2;OverlappingExonsClinicallyRelevant=15;HGVSg=NC_000006.12:g.36748184_36748303dup;HGVScClinicallyRelevant=NM_020939.2:c.972-36_1018+37dup;HGVSpClinicallyRelevant=NP_065990.1:p.N341Pfs*27;ISCNCytobandNotation=dup(6)p21.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=36748303	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:127.908:4.28331:1.66841:0.000189065744540861:CPNE5::CPNE5:NM_020939.2:VUS:2L0ThiscnvpartiallyoverlapstheCPNE5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
6	138162070	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=3;Span=120;GeneNames=ARFGEF3;GeneIDs=57221;Aliases=A7322,BIG3,C6orf92,KIAA1244,PPP1R33,dJ171N11.1;Genes=1;TranscriptNameClinicallyRelevant=NM_020340.5;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000006.12:g.138162070_138162189dup;HGVScClinicallyRelevant=NM_020340.5:c.1_85+18dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(6)q23.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=138162189	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:134.9:4.31372:1.66338:0.000169841094988274:ARFGEF3::ARFGEF3:NM_020340.5:VUS:2L0ThiscnvpartiallyoverlapstheARFGEF3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	142876729	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=1046;GeneNames=TRPV6;GeneIDs=55503;Aliases=ABP/ZF,CAT1,CATL,ECAC2,HRPTTN,HSA277909,LP6728,ZFAB;Genes=1;TranscriptNameClinicallyRelevant=NM_018646.6;OverlappingExonsClinicallyRelevant=3-5;HGVSg=NC_000007.14:g.142876729_142877774dup;HGVScClinicallyRelevant=NM_018646.6:c.347-1_706+10dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(7)q34;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=142877774	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:152.167:3.22425:1.35446:1.07622910830071e-06:TRPV6::TRPV6:NM_018646.6:VUS:2L0ThiscnvpartiallyoverlapstheTRPV6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
8	7332413	.	N	<DEL>	.	.	Type=Loss;Targets=12;Samples2=2;Span=30555;GeneNames=FAM66B,USP17L1,USP17L4,ZNF705G;GeneIDs=100128890,401447,645402,100131980;Genes=4;TranscriptNameClinicallyRelevant=NR_027423.2,NM_001256873.1,NM_001256874.1,NM_001164457.3;OverlappingExonsClinicallyRelevant=1-2,All,All,3-7;HGVSg=NC_000008.11:g.7332413_7362967del;HGVScClinicallyRelevant=.,NM_001256873.1:c.27_1593del,.,.;HGVSpClinicallyRelevant=.,NP_001243802.1:p.G9ext?,.,.;ISCNCytobandNotation=del(8)p23.1;SequenceOntologyClinicallyRelevant=.,stop_lost,.,.;RegionClinicallyRelevant=.,exon,.,.;Region=8:7296545-7425456,8:7312955-7380497,8:7351920-7367788;Span2=128912,67543,15869;OverlapType=Within Region,Within Region,Partial Overlap;Name=gssvL122357,gssvL122379,gssvL122419;Frequency=0.0023,0.0044,0.0013;Type2=Loss,Loss,Loss;Region2=8:7333369-7379626;Span3=46258;OverlapType2=Partial Overlap;Type3=Deletion;Frequency2=0.00473373;DeletionFrequency=0.00473373;DuplicationFrequency=0;END=7362967	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:71.5383:-1.71649:0.523277:1.65603220331513e-07:FAM66B,USP17L1,USP17L4,ZNF705G::USP17L1:NM_001256873.1:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-37472inClinGenDosageSensitivity.,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
8	7447973	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=3;Span=38446;GeneNames=DEFB104B,DEFB106B,SPAG11B;GeneIDs=10407,503618,503841;Aliases=EDDM2B,EP2,EP2C,EP2D,HE2,HE2C,SPAG11;Genes=3;TranscriptNameClinicallyRelevant=NM_001040702.1,NM_001040704.2,NM_058201.4;OverlappingExonsClinicallyRelevant=All,All,All;HGVSg=NC_000008.11:g.7447973_7486418dup;HGVScClinicallyRelevant=.,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(8)p23.1;SequenceOntologyClinicallyRelevant=.,.,.;RegionClinicallyRelevant=.,.,.;Region=8:7336299-7514711,8:7409831-7528213,8:7409831-7598490;Span2=178413,118383,188660;OverlapType=Within Region,Within Region,Within Region;Name=gssvG36586,gssvG36593,gssvG36583;Frequency=0.0035,0.0016,0.0037;Type2=Gain,Gain,Gain;Region2=8:7343654-7534698,8:7409844-7482669,8:7433398-7482669,8:7454115-7542809;Span3=191045,72826,49272,88695;OverlapType2=Within Region,Partial Overlap,Partial Overlap,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.0544011,0.00371684,0.00152053,0.00202737;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.0544011,0.00371684,0.00152053,0.00202737;END=7486418	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:212.892:1.5366:1.51808:0.000418516288279002:DEFB104B,DEFB106B,SPAG11B::DEFB104B:NM_001040702.1:Benign:2D-1ThecnvissmallerthanthetriplobenignregionISCA-37472inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
8	7863459	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=2;Span=114500;GeneNames=DEFB4A,DEFB103A,FAM66E,SPAG11A,USP17L3,USP17L8,ZNF705B;GeneIDs=653423,414325,1673,100132396,100132103,392188,645836;Aliases=EDDM2A,HE2;Genes=7;TranscriptNameClinicallyRelevant=NM_004942.4,NM_001081551.4,NR_027424.1,NM_001081552.3,NM_001256871.1,NM_001256872.1,NM_001193630.1;OverlappingExonsClinicallyRelevant=All,All,1-2,4,All,All,All;HGVSg=NC_000008.11:g.7863459_7977958dup;HGVScClinicallyRelevant=.,.,.,NM_001081552.3:c.293-42_327dup,NM_001256871.1:c.1593_1593+1ins(1566),.,.;HGVSpClinicallyRelevant=.,.,.,.,NP_001243800.1:p.532Gext*522,.,.;ISCNCytobandNotation=dup(8)p23.1;SequenceOntologyClinicallyRelevant=.,.,.,transcript_ablation,stop_lost,.,.;RegionClinicallyRelevant=.,.,.,exon,exon,.,.;Region=8:7667461-8036387,8:7706040-7952372,8:7798647-7903250,8:7802093-7982308,8:7846578-7919637,8:7850239-8108655,8:7851992-7892867,8:7872528-7957429,8:7880901-7930428,8:7894514-8246289,8:7930248-8035497;Span2=368927,246333,104604,180216,73060,258417,40876,84902,49528,351776,105250;OverlapType=Within Region,Partial Overlap,Partial Overlap,Within Region,Partial Overlap,Within Region,Partial Overlap,Contains Region,Contains Region,Partial Overlap,Partial Overlap;Name=gssvG36574,gssvG36582,gssvG36599,gssvG36587,gssvG36606,gssvG36579,gssvG36619,gssvG36601,gssvG36624,gssvG36576,gssvG36602;Frequency=0.0019,0.0034,0.002,0.0011,0.0003,0.0004,0.0079,0.0083,0.0097,0.0017,0.0011;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=8:7777183-7972317,8:7903268-7951332,8:7930080-8008640;Span3=195135,48065,78561;OverlapType2=Partial Overlap,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.0305795,0.00473053,0.000506842;DeletionFrequency=0,0,0;DuplicationFrequency=0.0305795,0.00473053,0.000506842;END=7977958	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:147.696:1.82017:2.66832:5.23056006386714e-07:DEFB4A,DEFB103A,FAM66E,SPAG11A,USP17L3,USP17L8,ZNF705B::SPAG11A:NM_001081552.3:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-37472inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneSPAG11A.,2L0ThiscnvpartiallyoverlapstheSPAG11Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps6proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
8	141425035	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=PTP4A3;GeneIDs=11156;Aliases=PRL-3,PRL-R,PRL3;Genes=1;TranscriptNameClinicallyRelevant=NM_032611.3;OverlappingExonsClinicallyRelevant=3;HGVSg=NC_000008.11:g.141425035_141425154dup;HGVScClinicallyRelevant=NM_032611.3:c.106-13_198+14dup;HGVSpClinicallyRelevant=NP_116000.1:p.L37_D67dup;ISCNCytobandNotation=dup(8)q24.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=141425154	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:120.217:5.45199:1.64422:1.88275116389654e-06:PTP4A3::PTP4A3:NM_032611.3:VUS:2L0ThiscnvpartiallyoverlapsthePTP4A3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
10	100826993	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=PAX2;GeneIDs=5076;Aliases=FSGS7,PAPRS,PAX-2;Genes=1;TranscriptNameClinicallyRelevant=NM_000278.5;OverlappingExonsClinicallyRelevant=9;HGVSg=NC_000010.11:g.100826993_100827112dup;HGVScClinicallyRelevant=NM_000278.5:c.1022-16_1108+17dup;HGVSpClinicallyRelevant=NP_000269.3:p.L369_S370ins29;ISCNCytobandNotation=dup(10)q24.31;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=100827112	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:114.325:4.12952:1.71477:0.000321822206051563:PAX2:PAX2:PAX2:NM_000278.5:VUS:2I0ThevarianthasanunknownimpactonthePAX2geneoritisnotpredictedtoundergoNMD.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
10	113876511	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=1;Span=3183;GeneNames=NHLRC2;GeneIDs=374354;Aliases=FINCA;Genes=1;TranscriptNameClinicallyRelevant=NM_198514.4;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000010.11:g.113876511_113879693del;HGVScClinicallyRelevant=NM_198514.4:c.332-10_907del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(10)q25.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=113879693	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:72.0683:-4.19101:0.55733:1.96798858095358e-07:NHLRC2::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
11	117481163	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=DSCAML1;GeneIDs=57453;Aliases=DSCAM2;Genes=1;TranscriptNameClinicallyRelevant=NM_020693.4;OverlappingExonsClinicallyRelevant=13;HGVSg=NC_000011.10:g.117481163_117481282dup;HGVScClinicallyRelevant=NM_020693.4:c.2560-12_2656+11dup;HGVSpClinicallyRelevant=NP_065744.3:p.E886Afs*5;ISCNCytobandNotation=dup(11)q23.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=117481282	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:143.483:4.27437:1.75318:0.000195095634301171:DSCAML1::DSCAML1:NM_020693.4:VUS:2L0ThiscnvpartiallyoverlapstheDSCAML1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	4726660	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=526;GeneNames=ANKS3;GeneIDs=124401;Genes=1;TranscriptNameClinicallyRelevant=NM_133450.4;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000016.10:g.4726660_4727185dup;HGVScClinicallyRelevant=NM_133450.4:c.171-8_490dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p13.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=4727185	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:135.712:3.70041:1.61113:4.88993718335135e-06:ANKS3::ANKS3:NM_133450.4:VUS:2L0ThiscnvpartiallyoverlapstheANKS3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	23467586	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=1416;GeneNames=GGA2;GeneIDs=23062;Aliases=VEAR;Genes=1;TranscriptNameClinicallyRelevant=NM_015044.4;OverlappingExonsClinicallyRelevant=16-17;HGVSg=NC_000016.10:g.23467586_23469001dup;HGVScClinicallyRelevant=NM_015044.4:c.1621-5_1842dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p12.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=23469001	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:90.7917:3.48362:1.57397:1.71747374223653e-05:GGA2::GGA2:NM_015044.4:VUS:2L0ThiscnvpartiallyoverlapstheGGA2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	67645531	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=256;GeneNames=CARMIL2;GeneIDs=146206;Aliases=CARMIL2b,IMD58,LRRC16C,RLTPR;Genes=1;TranscriptNameClinicallyRelevant=NM_001013838.3;OverlappingExonsClinicallyRelevant=2-3;HGVSg=NC_000016.10:g.67645531_67645786dup;HGVScClinicallyRelevant=NM_001013838.3:c.41-9_186+9dup;HGVSpClinicallyRelevant=NP_001013860.1:p.V63Afs*16;ISCNCytobandNotation=dup(16)q22.1;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=67645786	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:147.883:3.63571:1.42985:7.16602387243358e-06:CARMIL2::CARMIL2:NM_001013838.3:VUS:2L0ThiscnvpartiallyoverlapstheCARMIL2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	70130423	.	N	<DUP>	.	.	Type=Gain;Targets=19;Samples2=1;Span=56139;GeneNames=CLEC18C,LOC400541,PDPR;GeneIDs=55066,400541,283971;Aliases=PDP3;Genes=3;TranscriptNameClinicallyRelevant=NM_173619.4,NR_126007.1,NM_017990.5;OverlappingExonsClinicallyRelevant=All,All,7-19;HGVSg=NC_000016.10:g.70130423_70186561dup;HGVScClinicallyRelevant=.,.,NM_017990.5:c.608_2640dup;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(16)q22.1;SequenceOntologyClinicallyRelevant=.,.,3_prime_UTR_variant;RegionClinicallyRelevant=.,.,UTR3;Region=16:70090445-70251178,16:70111451-70179141,16:70141045-70164354,16:70142379-70179141;Span2=160734,67691,23310,36763;OverlapType=Within Region,Partial Overlap,Contains Region,Contains Region;Name=gssvG15176,gssvG15182,gssvG15193,gssvG15186;Frequency=0.0038,0.0647,0.4569,0.002;Type2=Gain,Gain,Gain,Gain;Region2=16:70106838-70177676,16:70111452-70162599,16:70117625-70247875,16:70130436-70143532,16:70145441-70179141;Span3=70839,51148,130251,13097,33701;OverlapType2=Partial Overlap,Partial Overlap,Within Region,Contains Region,Contains Region;Type3=Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.00523737,0.755556,0.00101369,0.00118343,0.00067579;DeletionFrequency=0,0,0,0,0;DuplicationFrequency=0.00523737,0.755556,0.00101369,0.00118343,0.00067579;END=70186561	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:161.423:1.34958:1.31603:3.04618165172364e-07:CLEC18C,LOC400541,PDPR::PDPR:NM_017990.5:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46493inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggenePDPR.,2L0ThiscnvpartiallyoverlapsthePDPRgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	16734680	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=2;Span=54760;GeneNames=CCDC144A,FAM106C,USP32P1;GeneIDs=9720,162632,100129396;Genes=3;TranscriptNameClinicallyRelevant=NM_001382000.1,NR_170993.1,NR_003190.2;OverlappingExonsClinicallyRelevant=12-17,All,1-2;HGVSg=NC_000017.11:g.16734680_16789439dup;HGVScClinicallyRelevant=NM_001382000.1:c.2419-10_4278dup,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.;RegionClinicallyRelevant=exon,.,.;Region=17:16753287-16820986;Span2=67700;OverlapType=Partial Overlap;Name=gssvG16012;Frequency=0.4635;Type2=Gain;END=16789439	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:155.49:1.75981:1.38014:4.25443005535321e-06:CCDC144A,FAM106C,USP32P1::CCDC144A:NM_001382000.1:VUS:2G0TheCNVisoverlapsthetriplobenignregionISCA-46702inClinGenDosageSensitivitybutincludesadditionalmaterial.,2L0ThiscnvpartiallyoverlapstheCCDC144Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	27760624	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=6;Span=120;GeneNames=NOS2;GeneIDs=4843;Aliases=HEP-NOS,INOS,NOS,NOS2A;Genes=1;TranscriptNameClinicallyRelevant=NM_000625.4;OverlappingExonsClinicallyRelevant=24;HGVSg=NC_000017.11:g.27760624_27760743dup;HGVScClinicallyRelevant=NM_000625.4:c.3009_3010ins(120);HGVSpClinicallyRelevant=NP_000616.3:p.A964_K1003dup;ISCNCytobandNotation=dup(17)q11.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=27760743	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:111.9:5.07037:2.14508:9.47542135402854e-06:NOS2::NOS2:NM_000625.4:VUS:2L0ThiscnvpartiallyoverlapstheNOS2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	36165986	.	N	<DUP>	.	.	Type=Gain;Targets=18;Samples2=5;Span=94357;GeneNames=CCL3L3,CCL4L2,TBC1D3B,TBC1D3I;GeneIDs=414059,414062,9560,102724862;Aliases=PRC17;Genes=4;TranscriptNameClinicallyRelevant=NM_001001437.4,NM_001291475.2,NM_001001417.7,NM_001291463.2;OverlappingExonsClinicallyRelevant=All,All,All,6-14;HGVSg=NC_000017.11:g.36165986_36260342dup;HGVScClinicallyRelevant=.,.,.,NM_001291463.2:c.280-6_1650dup;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(17)q12;SequenceOntologyClinicallyRelevant=.,.,.,transcript_ablation;RegionClinicallyRelevant=.,.,.,exon;Region=17:36062076-36258922,17:36062076-36348456,17:36154369-36258902,17:36175569-36196858,17:36177443-36348456,17:36180216-36222804;Span2=196847,286381,104534,21290,171014,42589;OverlapType=Partial Overlap,Within Region,Partial Overlap,Contains Region,Partial Overlap,Contains Region;Name=gssvG16380,gssvG16376,gssvG16389,gssvG16427,gssvG16379,gssvG16405;Frequency=0.0331,0.0498,0.0034,0.234,0.009,0.007;Type2=Gain,Gain,Gain,Gain,Gain,Gain;Region2=17:36081657-36329049,17:36108281-36293667,17:36154492-36348436,17:36177444-36348456;Span3=247393,185387,193945,171013;OverlapType2=Within Region,Within Region,Within Region,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.45,0.0501774,0.1,0.025;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.45,0.0501774,0.1,0.025;END=36260342	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:193.049:1.37482:1.64114:3.82297156925675e-07:CCL3L3,CCL4L2,TBC1D3B,TBC1D3I::CCL3L3:NM_001001437.4:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46706inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	47582735	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=2975;GeneNames=NPEPPS;GeneIDs=9520;Aliases=AAP-S,MP100,PSA;Genes=1;TranscriptNameClinicallyRelevant=NM_006310.4;OverlappingExonsClinicallyRelevant=5-6;HGVSg=NC_000017.11:g.47582735_47585709dup;HGVScClinicallyRelevant=NM_006310.4:c.541-7_849+9dup;HGVSpClinicallyRelevant=NP_006301.3:p.A181_E283dup;ISCNCytobandNotation=dup(17)q21.32;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=47585709	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:80.0716:2.88112:1.45156:0.000392179560890775:NPEPPS::NPEPPS:NM_006310.4:Benign:2L0ThiscnvpartiallyoverlapstheNPEPPSgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
19	15479313	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=29317;GeneNames=CYP4F22,PGLYRP2;GeneIDs=114770,126410;Aliases=HMFT0141,PGLYRPL,PGRP-L,PGRPL,TAGL-like,tagL,tagL-alpha,tagl-beta;Genes=2;TranscriptNameClinicallyRelevant=NM_173483.4,NM_052890.4;OverlappingExonsClinicallyRelevant=1,1;HGVSg=NC_000019.10:g.15479313_15508629dup;HGVScClinicallyRelevant=.,NM_052890.4:c.59_60ins(59);HGVSpClinicallyRelevant=.,NP_443122.3:p.A21Wfs*54;ISCNCytobandNotation=dup(19)p13.12;SequenceOntologyClinicallyRelevant=.,initiator_codon_variant;RegionClinicallyRelevant=.,exon;END=15508629	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:125.981:2.79229:1.37667:2.47863101208305e-05:CYP4F22,PGLYRP2::PGLYRP2:NM_052890.4:VUS:2L0ThiscnvpartiallyoverlapsthePGLYRP2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	46120317	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=7;Span=4380;GeneNames=IGFL3;GeneIDs=388555;Aliases=UNQ483;Genes=1;TranscriptNameClinicallyRelevant=NM_207393.2;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000019.10:g.46120317_46124696del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(19)q13.32;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;Region=19:46118137-46125855;Span2=7719;OverlapType=Within Region;Name=gssvL58890;Frequency=0.0591;Type2=Loss;Region2=19:46119324-46125004,19:46119349-46124997,19:46119478-46125055,19:46120276-46127512;Span3=5681,5649,5578,7237;OverlapType2=Within Region,Within Region,Within Region,Within Region;Type3=Deletion,Deletion,Deletion,Deletion;Frequency2=0.135556,0.125,0.0502114,0.0295858;DeletionFrequency=0.135556,0.125,0.0502114,0.0295858;DuplicationFrequency=0,0,0,0;END=46124696	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:95.3352:-2.82663:0.614546:6.85920632710342e-07:IGFL3::IGFL3:NM_207393.2:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-46714inClinGenDosageSensitivity.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
19	54725233	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=1;Span=10873;GeneNames=KIR3DL3;GeneIDs=115653;Aliases=CD158Z,KIR3DL7,KIR44,KIRC1;Genes=1;TranscriptNameClinicallyRelevant=NM_153443.5;OverlappingExonsClinicallyRelevant=2-8;HGVSg=NC_000019.10:g.54725233_54736105dup;HGVScClinicallyRelevant=NM_153443.5:c.35-14_1233dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.42;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=54736105	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:199.136:1.92829:1.52197:3.93031671382873e-05:KIR3DL3::KIR3DL3:NM_153443.5:Benign:2L0ThiscnvpartiallyoverlapstheKIR3DL3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
20	3822108	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=1;Span=2198;GeneNames=AP5S1;GeneIDs=55317;Aliases=C20orf29;Genes=1;TranscriptNameClinicallyRelevant=NM_018347.3;OverlappingExonsClinicallyRelevant=2-3;HGVSg=NC_000020.11:g.3822108_3824305del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(20)p13;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=3824305	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:69.6277:-4.31385:0.580989:8.53238193130784e-08:AP5S1::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
21	41837939	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=3;Span=9261;GeneNames=PRDM15;GeneIDs=63977;Aliases=C21orf83,PFM15,ZNF298;Genes=1;TranscriptNameClinicallyRelevant=NM_001040424.3;OverlappingExonsClinicallyRelevant=6-8;HGVSg=NC_000021.9:g.41837939_41847199dup;HGVScClinicallyRelevant=NM_001040424.3:c.539-8_996dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(21)q22.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=41847199	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:130.417:2.68596:1.36339:2.76479625644556e-06:PRDM15::PRDM15:NM_001040424.3:VUS:2L0ThiscnvpartiallyoverlapsthePRDM15genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
22	35084382	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=7;Span=178085;GeneNames=HMGXB4,ISX,LINC01399;GeneIDs=91464,104310353,10042;Aliases=Pix-1,RAXLX;Genes=3;TranscriptNameClinicallyRelevant=NM_001003681.3,NM_001303508.2,NR_126356.1;OverlappingExonsClinicallyRelevant=1-2,4-5,All;HGVSg=NC_000022.11:g.35084382_35262466dup;HGVScClinicallyRelevant=NM_001003681.3:c.1_31+45dup,NM_001303508.2:c.382-1_738dup,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(22)q12.3;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation,.;RegionClinicallyRelevant=exon,exon,.;END=35262466	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:134.827:2.57658:1.33254:6.97453178853846e-06:HMGXB4,ISX,LINC01399::HMGXB4:NM_001003681.3:VUS:2L0ThiscnvpartiallyoverlapstheHMGXB4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
X	284191	.	N	<DUP>	.	.	Type=Gain;Targets=30;Samples2=1;Span=89451;GeneNames=GTPBP6,LINC00685,PLCXD1,PPP2R3B;GeneIDs=55344,8225,283981,28227;Aliases=LL0XNC01-136G2.1;Genes=4;TranscriptNameClinicallyRelevant=NM_012227.4,NR_027231.1,NM_018390.4,NM_013239.5;OverlappingExonsClinicallyRelevant=All,All,2-7,2-13;HGVSg=NC_000023.11:g.284191_373641dup;HGVScClinicallyRelevant=.,.,NM_018390.4:c.4_972dup,NM_013239.5:c.325-12051_1728dup;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(X)p22.33;SequenceOntologyClinicallyRelevant=.,.,3_prime_UTR_variant,transcript_ablation;RegionClinicallyRelevant=.,.,UTR3,exon;Region2=X:251546-312771;Span3=61226;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.025;DeletionFrequency=0;DuplicationFrequency=0.025;END=373641	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:161.761:2.41501:1.25826:5.57649629068273e-31:GTPBP6,LINC00685,PLCXD1,PPP2R3B::PPP2R3B:NM_013239.5:VUS:2L0ThiscnvpartiallyoverlapsthePPP2R3Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
